GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Kanabo Group PLC (LSE:KNB) » Definitions » YoY EBITDA Growth

Kanabo Group (LSE:KNB) YoY EBITDA Growth : -42.86% (As of Dec. 2023)


View and export this data going back to 2017. Start your Free Trial

What is Kanabo Group YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Kanabo Group's YoY EBITDA Growth for the quarter that ended in Dec. 2023 was -42.86%.

Kanabo Group's EBITDA per Share for the six months ended in Dec. 2023 was £-0.01.

Kanabo Group YoY EBITDA Growth Historical Data

The historical data trend for Kanabo Group's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kanabo Group YoY EBITDA Growth Chart

Kanabo Group Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
YoY EBITDA Growth
Get a 7-Day Free Trial -140.00 83.33 -600.00 - 14.29

Kanabo Group Semi-Annual Data
Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -28.57 -75.00 22.22 85.71 -42.86

Kanabo Group YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Kanabo Group's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

YoY EBITDA Growth (A: Dec. 2023 )
=(EBITDA per Share (A: Dec. 2023 )-EBITDA per Share (A: Dec. 2022 ))/ | EBITDA per Share (A: Dec. 2022 ) |
=(-0.012--0.014)/ | -0.014 |
=14.29 %

Kanabo Group's YoY EBITDA Growth for the quarter that ended in Dec. 2023 is calculated as:

YoY EBITDA Growth (Q: Dec. 2023 )
=(EBITDA per Share (Q: Dec. 2023 )-EBITDA per Share (Q: Dec. 2022 )) / | EBITDA per Share (Q: Dec. 2022 )) |
=(-0.01--0.007)/ | -0.007 |
=-42.86 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kanabo Group YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Kanabo Group's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Kanabo Group Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Kanabo Group PLC (LSE:KNB) » Definitions » YoY EBITDA Growth
Comparable Companies
LSE:TLY HCA SZSE:300015 SAU:4013 HKSE:06618 XTER:FRE BKK:BDMS XKLS:5225 BSP:RDOR3 XTER:FME UHS CHE NSE:APOLLOHOSP AGL ASX:RHC DVA ACHC BOM:543220 EHC BKK:BH
Traded in Other Exchanges
3WD:Germany
Address
137-139 Brent Street, Churchill House, London, GBR, NW4 4DJ
Website
https://www.kanabogroup.com
Kanabo Group PLC is a research and development company engaged in selling a range of THC-Free retail CBD products in the markets and it is in the process of developing medical cannabis products. Its reportable segments include Primary Care and Secondary Care. The Primary Care segment includes Tele pharma services provided by GPS and The Secondary Care segment includes the development and distribution of cannabis-derived medical and wellness products. Geographically company has a presence in the United Kingdom, Israel, and others.

Kanabo Group Headlines

No Headlines